In a move poised to reshape the global metabolic API landscape, leading Viking pharmaceutical company Valhalla Labs has announced a groundbreaking strategic alliance with a leading American Tirzepatide firm. This partnership will see both entities collaborate on streamlining the supply chain for metabolic APIs, ensuring uninterrupted access to vita